Additional Information
Market: OTCBB
Sector: Pharmaceuticals & Biotechnology
EPIC: BONU
Latest Price: $0.10  (0,00%)
52-week High: $0.00
52-week Low: $0.00
Market Cap: $10.30M
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
BioNeutral Group
www.bioneutralgroup.com

Headquartered at the New Jersey Institute of Technology in Newark, New Jersey is a Life Science specialty chemical company with a focus on commercializing a game changing environmentally safe combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous microorganisms including bacteria, viruses, mold and difficult to eliminate health threatening spores. Using this approach BioNeutral has developed a cutting edge disruptive family of products initially focused in the health care arena and in National Defense . These ground breaking products have been approved for use in Germany, US/EPA approval is expected in mid 2010.

Pdf

BioNeutral tests Ogiene at Doubletree hotel in Jersey City with positive results

19th Oct 2010, 2:56 pm Ogiene performed well on stains that previously could not be removed by professional cleaners

BioNeutral Group (OTCBB: BONU) said Tuesday it tested its Ogiene multipurpose cleaner at the Doubletree Hotel in Jersey City with positive results.

The cleaning products maker said the Ogiene cleaner gave "excellent performance" on a variety of stains that previously could not be removed by professional cleaners.

The general manager of the Doubletree Hotel, Sam Calello, spoke of the product's performance on his property: "I can honestly say that your product removed stains and gum in our guest room carpeting, elevators, chairs and hallway carpeting. Not only is your product a winner, but it is environmentally safe."

Doubletree said it intends to showcase the product at its next corporate meeting to its associate hotels, including The SoHo Grand Hotel and the Tribeca Grand Hotel in New York City, as well as the Sheraton Lincoln Harbor Hotel in New Jersey.

"High-traffic areas like hotels, office buildings and transportation centers are ideal for our Ogiene Multipurpose Cleaner, once decision-makers see the product in action, we are confident they will want to integrate it into their regular cleaning regimens," said chief scientist of BioNeutral, Dr. Andy Kielbania.

BioNeutral has developed a technology platform that neutralizes harmful environmental contaminants and micro-organisms including bacteria, viruses, mold, fungi and spores. The company's products, Ygiene and Ogiene, kill germs and clean surfaces, effective in surface, water and airborne applications.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.